Merit Financial Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$565K Buy
6,360
+840
+15% +$79.6K ﹤0.01% 1508
2026
Q2
$475K Sell
5,520
-207
-4% -$18.2K ﹤0.01% 1529
2026
Q1
$518K Buy
5,727
+288
+5% +$26.4K ﹤0.01% 1359
2025
Q4
$489K Sell
5,439
-535
-9% -$50.7K ﹤0.01% 1319
2025
Q3
$588K Sell
5,974
-553
-8% -$54.8K 0.01% 1086
2025
Q2
$595K Buy
6,527
+2,836
+77% +$274K 0.01% 1019
2025
Q1
$418K Buy
3,691
+27
+0.7% +$2.89K 0.01% 1013
2024
Q4
$387K Sell
3,664
-1,494
-29% -$160K 0.01% 820
2024
Q3
$557K Sell
5,158
-957
-16% -$104K 0.01% 536
2024
Q2
$664K Sell
6,115
-1,048
-15% -$124K 0.01% 514
2024
Q1
$871K Buy
+7,163
New +$895K 0.02% 442

Other funds holding ZBH

Merit Financial Group's ZBH Position: Q3 2026 in Review

Merit Financial Group increased its Zimmer Biomet (ZBH) stake by 15% in Q3 2026, buying an estimated $79.6K and bringing the position to 6,360 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

Merit Financial Group first reported a position in ZBH in Q1 2024 and has held it in 11 quarters since. The position peaked at $871K in Q1 2024. 829 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Merit Financial Group held 6,360 shares of Zimmer Biomet worth $565K as of Q3 2026.
  • Merit Financial Group bought 840 Zimmer Biomet shares in Q3 2026, an estimated $79.6K.
  • Zimmer Biomet made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1508 holding.
  • Merit Financial Group first reported a position in Zimmer Biomet in Q1 2024 and has held it in 11 quarters since.
  • Merit Financial Group's Zimmer Biomet position peaked at $871K in Q1 2024.
  • 829 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.